Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001562180-25-002293 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-11 | 2025-03-07 | EWTX | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $30.00 | -100 | 14.5K | -0.7% | -$3,000 |
| DT | 2025-03-11 | 2025-03-07 | EWTX | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.18 | +100 | 14.6K | +0.7% | +$18 |
| DT | 2025-03-11 | 2025-03-07 | EWTX | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | -100 | 41.5K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | S | D | 100 | $30.00 | 14,478 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-07 | M | A | 100 | $0.18 | 14,578 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-03-07 | M | D | 100 | $0.00 | 41,545 | D | $0.18 · 2021-06-13 to 2027-08-08 | 100 Common Stock |